Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,831 | -2,514 | -2,172 | 191 | -1,960 |
| Accounts payable and accrued liabilities | 63 | -230 | 565 | 383 | 484 |
| Other Working Capital | 747 | 872 | -261 | 80 | -972 |
| Other Operating Activity | 395 | 449 | -5,582 | -5,564 | -996 |
| Operating Cash Flow | $-3,625 | $-1,424 | $-7,450 | $-4,911 | $-3,444 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -40,570 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-40,570 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 11,888 | 11,888 | N/A |
| Common Stock Issued | 46,412 | N/A | 810 | 810 | N/A |
| Other Financing Activity | 0 | 0 | -1,549 | -1,455 | 0 |
| Financing Cash Flow | $46,412 | $N/A | $11,149 | $11,243 | $N/A |
| Beginning Cash Position | 7,793 | 7,793 | 4,094 | 4,094 | 4,094 |
| End Cash Position | 10,009 | 6,369 | 7,793 | 10,425 | 650 |
| Net Cash Flow | $2,216 | $-1,424 | $3,699 | $6,331 | $-3,444 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,625 | -1,424 | -7,450 | -4,911 | -3,444 |
| Free Cash Flow | -3,625 | -1,424 | -7,450 | -4,911 | -3,444 |